Navigation Links
Myelin Removal Beads: Premium Efficiency for Neural Cell Separations and Antibody Stainings
Date:5/20/2009

BERGISCH GLADBACH, Germany, May 20 /PRNewswire/ -- Miltenyi Biotec announces the worldwide and exclusive release of Myelin Removal Beads. Myelin is a specialized membrane which ensheathes and insulates axons in the peripheral and central nervous system. During preparation of single-cell suspensions, myelin membrane fragments represent the major contaminant. "When dissociating adult neural tissue, usually less than 5 percent of the cell suspension consists of cells. The rest corresponds to cell debris", explains Dr. Rebecca Biloune, Product Manager for Neural Research Products at Miltenyi Biotec. "Removal of myelin leads to higher purity and recovery of target cells."

The novel product is suited for myelin removal from single-cell suspensions obtained from human, mouse, and rat tissues and is especially recommended prior to cell separations and cell stainings with Anti-Prominin-1 , CD133, Anti-PSA-NCAM, Anti-A2B5, or CD11b (microglia) MicroBeads and fluorochrome-conjugated antibodies, respectively.

"The beads work seamlessly with other MACS Technology products", adds Dr. Biloune. "Contaminating myelin fragments can be depleted either by manual protocols or by automated magnetic separations with the autoMACS(TM) Separator or the MACSQuant(TM) Analyzer." Myelin Removal Beads are exclusively available from Miltenyi Biotec. Detailed information is available at http://www.myelinremoval.com.

About Miltenyi Biotec

The company is one of the largest and most successful biotechnology companies in Germany. More than 1,100 employees worldwide develop, produce and sell products for biomedical research and clinical applications. The renowned MACS Technology for magnetic separation of cells has become a standard technology in research laboratories worldwide.

    Contact
    Prof. Dr. Uwe Heinlein, Corporate Communications, 
'/>"/>
SOURCE Miltenyi Biotec GmbH
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Applisonix Announces Breakthrough in Ultrasound Technology for Hair Removal - Average Hair Reduction of 38% Following Initial Treatment
2. Novare Announces Completion of First Pediatric Single Port Spleen Removal Using RealHand(R) HD Instruments
3. September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging
4. Gallbladder Removal Through Vagina Offers Minimally Invasive Alternative
5. AUA Guideline: Full Kidney Removal Not Necessary for All Kidney Tumors
6. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
7. Neuralstem Announces Issuance of Core Technology Patent in Europe
8. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
9. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
10. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
11. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ov. 25 The FDA granted traditional..., a non-nucleoside reverse transcriptase inhibitor... indicated for use in treatment-experienced adults... strains resistant to an NNRTI and other antiretro...ased on 48-week data from two Phase 3 studies know...
(Date:11/25/2009)..., Nov. 25 Remedium Tech...m-like foam that stops severe bleeding, won first ...dea category of the Global Security Challenge 2009... from more than 100 entries from around the world,...C Security Summit conference held at the London Sc...
(Date:11/25/2009)...., Nov. 25 Regado Biosciences, a p...ntithrombotic aptamers with active control agents,...t, will be presenting at the Piper Jaffray 21st An... Hotel in New York City. Dr. Mazzo,s presentation...r 1 and will include an overview of the Company,s ...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2VA Secretary Hits the Road to Highlight 22United We Serve 22 Effort 49658 1VA Secretary Hits the Road to Highlight 22United We Serve 22 Effort 49658 2HIV Atlas Shows Virus Targeting Minorities 49655 1HIV Atlas Shows Virus Targeting Minorities 49655 2HIV Atlas Shows Virus Targeting Minorities 49655 3Dragon Pharma Announces Results of 2009 Annual General Meeting 12730 1
... Suggests that Adding Singulair to Advair Offers n...l Asthma Control, RESEARCH TRIANGLE PARK, N.C. an...ts with both asthma and allergic rhinitis, or seas...g function when treated with Advair,Diskus(R) (flu...er) as,compared with Singulair (montelukast sodium...
...ALE, N.J., May 16 Memory Pharmaceuticals,Corp. (N...al key development,programs at its R&D Day meeting...ed new clinical data for MEM 1414, its lead PDE4 i... in humans. In addition, the,Company has nominated...its,5-HT6 antagonist program, and separately confi...
Other Medicine Technology:Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM) 2Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM) 3Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 2Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 3Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 4
(Date:11/30/2009)... Firm uses Staten Island ... jury that defendants were 100% responsible for cl...New York (Lexis Nexis) November 30, 2009 -- A Stat...00 to a career union paperhanger who was injured a...he case, Sigismondi v. J.T. Magen Construction Com...
(Date:11/30/2009)..., , CLEVELAND, Ohio, November 30 /PR...s leading developer of medical simulation systems,...be offering a PROcedure Rehearsal Studio(TM),works...g in Frankfurt,Germany. , The Simbionix ...t medical,simulator to enable clinicians to create...
(Date:11/30/2009)... CHICAGO Elastography is an effective, convenien... helps distinguish cancerous breast lesions from b...nted today at the annual meeting of the Radiologic...graphy yields suspicious findings, physicians ofte... However, ultrasound has the potential to result i...
(Date:11/29/2009)... The Academy of General D... Orange county CA, received the Mastership Award d...gnizes AGD members, commitment to excellence in de...mpleted 1,100 hours of approved continuing dental ...uding 400 hours dedicated to hands-on skills and t...
(Date:11/29/2009)...For well-being, a $1,300 round of treatment equals..., SATURDAY, Nov. 28 (HealthDay News) -- Psychologi...eople happy than getting a raise or winning a lott...hers analyzed data on thousands of people who prov... found that the increase in happiness from a $1,32...
Breaking Medicine News(10 mins):Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Elastography reduces unnecessary breast biopsies 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2
...revealed that regular application of make-up could...udy says on an average a woman applies 175 chemica... of cosmetics and toiletries. Most of those ch...gist and spokesman for the British Skin Foundation...
...that when the hormone progestin is taken as a part...nopause//, deficits in hearing sensitivity and aud...d according to a research team at the Rochester Sc...aring. The study's lead researcher, Doctor Robert ...
...eath boards (DHB) has led to the development of pr...ospital //waiting lists in one shot before the end...t’s requirement that only patients who can be guar...re referred back to their GP for monitoring. ...
... that the world's first successful womb transplant...ars.// Women unable to have children because...e an emergency hysterectomy will be benefited from... New York and Budapest. In 2000, a 26-year-o...
...y have identified key compounds that stimulate ste...whose findings, is set to appear in the September ...covery might one day lead to restored function for...ve explained that this could provide important clu...
... on the spread of a rare HIV-2 virus. // Jap...uld step up vigilance against the rare HIV-2 form ...ed that the first Japanese citizen has been infect... submit written reports as to how they are conduct...
Other Medicine News:Health News:Hearing May be affected by Certain Hormone Replacement Therapies 2Health News:800 Patients to be Dumped from Hospital Waiting Lists 2
Ellik Evacuator
Ellik Evacuator, includes glass body, male connector tubing, and latex bulb
Aspect100U
Intra Operative "Cysto" Suite
Medicine Products: